NSE filing, NSE: MOLBIO. Summary written from the filing by ALFA Finder's alert engine.
Molbio Diagnostics Ltd: key numbers
- Share price
- ₹1,274.00
- Market cap
- ₹14,682 Cr
- Revenue (annual)
- ₹1,446 Cr
- Net profit (annual)
- ₹166.6 Cr
- Promoter holding
- 41.29%
- FII holding
- 1.59%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Molbio Diagnostics Ltd
All →Molbio Diagnostics Price Movement Clarification
Molbio Diagnostics responded to NSE's spurt-in-volume query, stating the movement is purely market-driven. No pending price-sensitive information is slated for disclosure.
Molbio Diagnostics Other Announcement
Molbio Diagnostics Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure provides information on promoter and public shareholding structures.
Molbio Diagnostics Capital Structure Change
Kotak Mahindra Mutual Fund acquired 5,70,000 Molbio Diagnostics shares in the open market on 08 October 2026. Its stake crossed 5% to 5.4834%.
Molbio Diagnostics Other Announcement
Molbio Diagnostics Limited re-appointed M/s. K.S. Kamalakara & Co as Cost Auditors for a 12-month term. The decision was finalized during a board meeting on September 25, 2026.
- Execution
- 12 months
Molbio Diagnostics Board Meeting Outcome
Molbio Diagnostics Limited has re-appointed M/s K. S. Kamalakara & Co as its Cost Auditor for the financial year 2026-27. The Board approved the appointment today.
- Execution
- Financial Year 2026-27
Molbio Diagnostics Capital Structure Change
India Business Excellence Fund III sold 30,00,000 shares (2.60% stake) of Molbio Diagnostics Limited. The transaction was executed via open market on September 23, 2026.
Other board meeting date announcements
All →Banas Finance Board Meeting Date
Banas Finance schedules a board meeting on 5 November 2026 to approve unaudited Q2 and half-year results. Trading window stays closed until 48 hours after results declaration.
Thirumalai Chemicals Board Meeting Date
Thirumalai Chemicals has informed the exchanges that its board will meet on November 5, 2026. The meeting will consider unaudited results for the quarter and half year ended September 30, 2026.
Super Spinning Mills Board Meeting Date
Super Spinning Mills schedules its board meeting for November 5, 2026 to consider unaudited quarterly results. Trading window stays closed until 48 hours after the meeting.
Lead Reclaim and Rubber Products Board Meeting Date
Lead Reclaim will meet on 05 November 2026 to consider half-yearly unaudited results for September 2026. Trading window remains closed until 07 November 2026.
Oval Projects Engineering Board Meeting Date
Oval Projects Engineering will hold a board meeting on November 4, 2026 to consider half-year results and a warrant issue. Agenda items are proposed; no amount stated.
Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.